Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
1985 and 1986 were milestones for those who study atherosclerosis. In those years took place the USA Consensus Conference, followed first by the Italian Consensus Conference and then by the European one. They marked the final solution to the querelle on cholesterol and ischemic cardiopathy. On the basis of the results obtained from the Coronary Primary Prevention Trial (CPPT), plasmatic cholesterol is now no longer considered a risk factor in cardiovas- cular diseases, but the cause of atherosclerosis and its organ damages. This was also the basic statement that came out of the 6th International Congress on Atherosclerosis and Cardiovascular Diseases . The meeting was attended by specialists from various countries representing different experimental ap- proaches to the cardiovascular diseases, from basic research (receptor pathol- ogy, apoproteins physiopathology); to epidemiology (both observational study and prevention); to pure cardiology in its aspects of physiopathology, diagnosis and therapy; to the new invasive and non-invasive diagnostic methods; and to the presentation of studies which correlate new variables (serotonin, en- dogenous opioids) with the atheromasic disease. The final outcome of this re- search is therapy, be it a pharmacological, nutritional and/or surgical one. Il- lustrious names from five continents dealt with a wide a range of topics, and their presentations produced a wealth of data. The presentations contained in this volume are the corpus of the congress and will serve as a precise updat- ing for all specialists, physicians and students.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
1985 and 1986 were milestones for those who study atherosclerosis. In those years took place the USA Consensus Conference, followed first by the Italian Consensus Conference and then by the European one. They marked the final solution to the querelle on cholesterol and ischemic cardiopathy. On the basis of the results obtained from the Coronary Primary Prevention Trial (CPPT), plasmatic cholesterol is now no longer considered a risk factor in cardiovas- cular diseases, but the cause of atherosclerosis and its organ damages. This was also the basic statement that came out of the 6th International Congress on Atherosclerosis and Cardiovascular Diseases . The meeting was attended by specialists from various countries representing different experimental ap- proaches to the cardiovascular diseases, from basic research (receptor pathol- ogy, apoproteins physiopathology); to epidemiology (both observational study and prevention); to pure cardiology in its aspects of physiopathology, diagnosis and therapy; to the new invasive and non-invasive diagnostic methods; and to the presentation of studies which correlate new variables (serotonin, en- dogenous opioids) with the atheromasic disease. The final outcome of this re- search is therapy, be it a pharmacological, nutritional and/or surgical one. Il- lustrious names from five continents dealt with a wide a range of topics, and their presentations produced a wealth of data. The presentations contained in this volume are the corpus of the congress and will serve as a precise updat- ing for all specialists, physicians and students.